These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 8735967
21. Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding. Feigenbaum JJ, Simantov R. Neurosci Lett; 1996 Jul 05; 212(1):5-8. PubMed ID: 8823749 [Abstract] [Full Text] [Related]
22. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes. Lester PA, Traynor JR. Brain Res; 2006 Feb 16; 1073-1074():290-6. PubMed ID: 16443205 [Abstract] [Full Text] [Related]
23. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Collin E, Frechilla D, Pohl M, Bourgoin S, Le Bars D, Hamon M, Cesselin F. Brain Res; 1993 Apr 23; 609(1-2):211-22. PubMed ID: 8389648 [Abstract] [Full Text] [Related]
24. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices. Schlösser B, Kudernatsch MB, Sutor B, ten Bruggencate G. Neurosci Lett; 1995 May 19; 191(1-2):126-30. PubMed ID: 7659278 [Abstract] [Full Text] [Related]
25. Stimulation of mu and delta opioid receptors induces hyperalgesia while stimulation of kappa receptors induces antinociception in the hot plate test in the naked mole-rat (Heterocephalus glaber). Towett PK, Kanui TI, Juma FD. Brain Res Bull; 2006 Dec 11; 71(1-3):60-8. PubMed ID: 17113929 [Abstract] [Full Text] [Related]
26. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors. Pacheco Dda F, Romero TR, Duarte ID. Brain Res; 2014 May 08; 1562():69-75. PubMed ID: 24675031 [Abstract] [Full Text] [Related]
27. Inhibition of calcium currents in rat colon sensory neurons by K- but not mu- or delta-opioids. Su X, Wachtel RE, Gebhart GF. J Neurophysiol; 1998 Dec 08; 80(6):3112-9. PubMed ID: 9862909 [Abstract] [Full Text] [Related]
28. Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappa receptor agonist-induced G-protein activation in the guinea pig caudate: further evidence of kappa receptor heterogeneity. Heyliger SO, Jackson C, Rice KC, Rothman RB. Synapse; 1999 Dec 15; 34(4):256-65. PubMed ID: 10529720 [Abstract] [Full Text] [Related]
29. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth. Hatzoglou A, Bakogeorgou E, Papakonstanti E, Stournaras C, Emmanouel DS, Castanas E. J Cell Biochem; 1996 Dec 15; 63(4):410-21. PubMed ID: 8978457 [Abstract] [Full Text] [Related]
30. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Schoffelmeer AN, Hogenboom F, Mulder AH. Br J Pharmacol; 1997 Oct 15; 122(3):520-4. PubMed ID: 9351509 [Abstract] [Full Text] [Related]
31. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat. Vankova ME, Weinger MB, Chen DY, Bronson JB, Motis V, Koob GF. Anesthesiology; 1996 Sep 15; 85(3):574-83. PubMed ID: 8853088 [Abstract] [Full Text] [Related]
32. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. Matsumoto RR, Brinsfield KH, Patrick RL, Walker JM. J Pharmacol Exp Ther; 1988 Jul 15; 246(1):196-203. PubMed ID: 2839661 [Abstract] [Full Text] [Related]
33. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine. Townsend D, Portoghese PS, Brown DR. J Pharmacol Exp Ther; 2004 Jan 15; 308(1):385-93. PubMed ID: 14569065 [Abstract] [Full Text] [Related]
34. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux. Tao R, Ma Z, Thakkar MM, McCarley RW, Auerbach SB. Neuroscience; 2007 Jun 15; 147(1):106-16. PubMed ID: 17499930 [Abstract] [Full Text] [Related]
35. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. Pena-dos-Santos DR, Severino FP, Pereira SA, Rodrigues DB, Cunha FQ, Vieira SM, Napimoga MH, Clemente-Napimoga JT. Neuroscience; 2009 Nov 10; 163(4):1211-9. PubMed ID: 19647045 [Abstract] [Full Text] [Related]
36. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB. J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975 [Abstract] [Full Text] [Related]
37. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception. Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS. J Pharmacol Exp Ther; 2003 Dec 16; 307(3):1054-64. PubMed ID: 14557380 [Abstract] [Full Text] [Related]
38. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. Emmerson PJ, Liu MR, Woods JH, Medzihradsky F. J Pharmacol Exp Ther; 1994 Dec 16; 271(3):1630-7. PubMed ID: 7996478 [Abstract] [Full Text] [Related]
39. Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line. Kampa M, Margioris AN, Hatzoglou A, Dermitzaki I, Denizot A, Henry JF, Oliver C, Gravanis A, Castanas E. Eur J Pharmacol; 1999 Jan 08; 364(2-3):255-62. PubMed ID: 9932731 [Abstract] [Full Text] [Related]
40. Opioid-mediated facilitation of long-term depression in rat hippocampus. Wagner JJ, Etemad LR, Thompson AM. J Pharmacol Exp Ther; 2001 Mar 08; 296(3):776-81. PubMed ID: 11181906 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]